An Overview of MYC and Its Interactome

Conacci-Sorrell, M., McFerrin, L., Eisenman, R. N.·2014·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a014357

Cited by (412)

Items 401–412 of 412

  1. The GSEC-encoded polypeptide GESP drives colorectal cancer tumorigenesis via NPM1-c-Myc-mediated repression of NDRG1
    Yoshihiro Kawasaki, Tomoatsu Hayashi, Akane Kitta, Lumi Negishi, Sakiko Suda, Chiemi Furuya-Ikude, Nao Taniguchi, Tetsu Akiyama, Eisaku Kondo · 2026 · Oncogene
  2. Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer
    Ilaria Cassotti, Vito Fiume, Paolo Gandellini, Clelia Tiziana Storlazzi · 2026 · Biomarker Research
  3. Divergent c-MYC Expression Patterns in NET and NEC: Insights from a Multicentre Cohort of 1380 Neuroendocrine Neoplasms
    Maxime Schmitt, Katharina Ofner, Detlef Klaus Bartsch, Daniel‐Christoph Wagner, Anja Rinke, Thomas Gress, Marcus Kremer, Matthias Evert, Nic Gabriel Reitsam, Viktorie Koberova et al. · 2026 · Endocrine Pathology
  4. Temporal CRAC channel blockade modulates the MYC-MXD axis to attenuate autoimmune inflammation
    Beibei Wu, Spyridon Hasiakos, Shawn J. Cokus, Matthew Do, Elizabeth Kaplan, Matteo A. Pellegrini, Zuoming Sun, Reuben H. Kim, Sonal Srikanth, Yousang Gwack · 2026 · Cell Reports
  5. From timekeeping to divisions—Molecular links between circadian rhythms and cell cycle
    Sevde Goker, Junghyun Lee, Attila Csikász‐Nagy, Christian I. Hong · 2026 · FEBS Letters
  6. BindingDB Entry 50008601: Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
    BindingDB · 2021 · UC San Diego
  7. BindingDB Entry 50023669: Design, Synthesis, and Biological Evaluation of Thieno[3,2-d]pyrimidine Derivatives as the First Bifunctional PI3Kδ Isoform Selective/Bromodomain and Extra-Terminal Inhibitors.
    BindingDB · 2026 · UC San Diego
  8. BindingDB Entry 50021153: MYC the oncogene from hell: Novel opportunities for cancer therapy.
    BindingDB · 2025 · UC San Diego
  9. BindingDB Entry 50018504: Targeting MYC: From understanding its biology to drug discovery.
    BindingDB · 2024 · UC San Diego
  10. BindingDB Entry 50017413: Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective.
    BindingDB · 2023 · UC San Diego
  11. BindingDB Entry 50002796: Synthetic molecules for disruption of the MYC protein-protein interface.
    BindingDB · 2020 · UC San Diego
  12. Insights into MYC biology through investigation of synthetic lethal interactions with MYC deregulation
    Mai Sato · 2014